LEVONORGESTREL AND ETHINYL ESTRADIOL

LEVONORGESTREL AND ETHINYL ESTRADIOL was reported 2743 times

LEVONORGESTREL AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERSISTENT UROGENITAL SINUS 2 0.1250
1 TOLOSA-HUNT SYNDROME 3 0.0698
2 ECTROPION OF CERVIX 2 0.0455
3 HISTIOCYTIC NECROTISING LYMPHADENITIS 2 0.0230
4 UNWANTED PREGNANCY 3 0.0219
5 HEPATIC ADENOMA 10 0.0193
6 AMIMIA 2 0.0182
7 GINGIVAL GRAFT 2 0.0177
8 PERITONEAL EFFUSION 2 0.0148
9 DYSTHYMIC DISORDER 3 0.0090
10 RETINAL DYSTROPHY 2 0.0084
11 MENSTRUAL CLOTS 2 0.0083
12 CORNEAL REFLEX DECREASED 3 0.0080
13 CSF PRESSURE INCREASED 2 0.0075
14 SYRINGOMYELIA 2 0.0072
15 TUMOUR RUPTURE 4 0.0071
16 PORPHYRIA NON-ACUTE 3 0.0069
17 INTRACRANIAL VENOUS SINUS THROMBOSIS 6 0.0056
18 PNEUMOMEDIASTINUM 10 0.0055
19 PREGNANCY ON ORAL CONTRACEPTIVE 14 0.0053
20 OCCIPITAL NEURALGIA 3 0.0053
21 POLYCYSTIC OVARIAN SYNDROME 2 0.0052
22 PREGNANCY TEST POSITIVE 2 0.0051
23 HUMAN PAPILLOMA VIRUS TEST POSITIVE 2 0.0049
24 EOSINOPHILIC PNEUMONIA ACUTE 4 0.0046
25 PULMONARY VALVE STENOSIS CONGENITAL 2 0.0046
26 VULVAL DISORDER 3 0.0045
27 PERINATAL DEPRESSION 2 0.0044
28 NEUROSIS 2 0.0044
29 SLEEP-RELATED EATING DISORDER 4 0.0043
30 JARISCH-HERXHEIMER REACTION 3 0.0042
31 PULMONARY ARTERY THROMBOSIS 3 0.0039
32 INSULIN-LIKE GROWTH FACTOR DECREASED 2 0.0038
33 SUPERIOR SAGITTAL SINUS THROMBOSIS 3 0.0038
34 PREGNANCY ON CONTRACEPTIVE 5 0.0034
35 ADENOMYOSIS 2 0.0034
36 RECTOCELE 2 0.0033
37 CYTOLYTIC HEPATITIS 11 0.0033
38 ABNORMAL WITHDRAWAL BLEEDING 3 0.0033
39 INTERMENSTRUAL BLEEDING 17 0.0030
40 WISDOM TEETH REMOVAL 4 0.0030
41 INFUSION SITE DISCOMFORT 3 0.0029
42 LEIOMYOMA 2 0.0029
43 MAST CELL ACTIVATION SYNDROME 4 0.0028
44 SUSPICIOUSNESS 2 0.0028
45 CATAPLEXY 4 0.0028
46 METRORRHAGIA 47 0.0028
47 CEREBRAL VENOUS THROMBOSIS 5 0.0028
48 FIBROCYSTIC BREAST DISEASE 2 0.0027
49 OBSTRUCTIVE PANCREATITIS 2 0.0026
50 CHRONIC SPONTANEOUS URTICARIA 3 0.0026
51 POST-TRAUMATIC NECK SYNDROME 2 0.0025
52 SEIZURE CLUSTER 2 0.0024
53 COVID-19 IMMUNISATION 2 0.0024
54 VAGINAL ODOUR 3 0.0024
55 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
56 PERIORBITAL PAIN 2 0.0024
57 DRUG LEVEL FLUCTUATING 2 0.0023
58 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
59 MENSTRUAL DISORDER 18 0.0022
60 OVARIAN DISORDER 2 0.0021
61 PLACENTAL DISORDER 2 0.0021
62 GLUTEN SENSITIVITY 3 0.0021
63 MENOMETRORRHAGIA 4 0.0021
64 ENDOMETRIOSIS 10 0.0021
65 PYELOCALIECTASIS 2 0.0021
66 SLEEP PARALYSIS 3 0.0020
67 MESENTERIC VEIN THROMBOSIS 2 0.0020
68 PRODUCT MEASURED POTENCY ISSUE 2 0.0020
69 PSYCHOTIC BEHAVIOUR 2 0.0020
70 EYE COLOUR CHANGE 2 0.0020
71 ABNORMAL UTERINE BLEEDING 5 0.0019
72 MENORRHAGIA 38 0.0019
73 PRE-EXISTING CONDITION IMPROVED 12 0.0019
74 SINUSITIS BACTERIAL 2 0.0019
75 MIGRAINE WITH AURA 5 0.0018
76 INFECTIOUS MONONUCLEOSIS 4 0.0018
77 CEREBRAL THROMBOSIS 5 0.0018
78 DYSMENORRHOEA 23 0.0017
79 INTRUSIVE THOUGHTS 2 0.0017
80 HEAVY MENSTRUAL BLEEDING 15 0.0017
81 THROMBOPHLEBITIS SUPERFICIAL 5 0.0016
82 CHOLECYSTITIS CHRONIC 11 0.0016
83 MENSTRUATION IRREGULAR 44 0.0016
84 COELIAC DISEASE 16 0.0016
85 ECTOPIC PREGNANCY 5 0.0016
86 BLOOD UREA DECREASED 2 0.0016
87 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
88 MALLORY-WEISS SYNDROME 2 0.0016
89 OVARIAN CYST RUPTURED 2 0.0016
90 ALCOHOL INTERACTION 3 0.0015
91 GALLBLADDER INJURY 3 0.0015
92 UNINTENDED PREGNANCY 16 0.0015
93 LIP INJURY 2 0.0015
94 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
95 DYSPAREUNIA 7 0.0015
96 HYPOMENORRHOEA 4 0.0015
97 COMPULSIVE SHOPPING 3 0.0015
98 PREMENSTRUAL SYNDROME 2 0.0015
99 VAGINAL HAEMORRHAGE 63 0.0015
100 AKINESIA 3 0.0014
101 CHRONIC FATIGUE SYNDROME 2 0.0014
102 PELVIC PAIN 26 0.0014
103 INJECTION SITE HYPOAESTHESIA 2 0.0014
104 MENSTRUATION DELAYED 15 0.0014
105 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
106 RED BLOOD CELL COUNT ABNORMAL 2 0.0014
107 GENERALISED ANXIETY DISORDER 2 0.0014
108 HYPOMANIA 5 0.0014
109 PELVIC INFLAMMATORY DISEASE 2 0.0013
110 ACNE CYSTIC 4 0.0013
111 BREAST TENDERNESS 10 0.0013
112 PRODUCT LABEL ISSUE 9 0.0013
113 EPICONDYLITIS 2 0.0013
114 SNORING 5 0.0013
115 ORAL PRURITUS 3 0.0013
116 HAEMANGIOMA 3 0.0013
117 INFERTILITY FEMALE 2 0.0013
118 SINUS PAIN 3 0.0013
119 VAGINAL INFECTION 6 0.0013
120 INFUSION SITE PRURITUS 4 0.0013
121 STARING 3 0.0012
122 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
123 PITUITARY TUMOUR BENIGN 2 0.0012
124 ANTIBODY TEST POSITIVE 2 0.0012
125 UTERINE PERFORATION 10 0.0012
126 BILIARY DYSKINESIA 2 0.0012
127 ABORTION INDUCED 11 0.0012
128 POLYMENORRHOEA 4 0.0012
129 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
130 HANGOVER 4 0.0011
131 FEAR OF DISEASE 2 0.0011
132 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
133 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
134 ALCOHOL POISONING 3 0.0011
135 GASTROINTESTINAL INJURY 3 0.0011
136 LARYNGOSPASM 3 0.0011
137 GAMBLING DISORDER 3 0.0011
138 EMBEDDED DEVICE 11 0.0011
139 NO ADVERSE EFFECT 2 0.0011
140 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
141 OESOPHAGEAL SPASM 2 0.0011
142 AMENORRHOEA 19 0.0011
143 EOSINOPHILIC OESOPHAGITIS 3 0.0011
144 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
145 ROSACEA 5 0.0011
146 AURA 2 0.0011
147 PARANASAL SINUS DISCOMFORT 4 0.0011
148 EXERCISE TOLERANCE DECREASED 6 0.0010
149 OESOPHAGEAL ULCER 4 0.0010
150 MOTION SICKNESS 2 0.0010
151 NASAL POLYPS 5 0.0010
152 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
153 JOINT CREPITATION 2 0.0010
154 EMERGENCY CARE 3 0.0010
155 EMBOLISM VENOUS 3 0.0010
156 PRODUCT COLOUR ISSUE 5 0.0010
157 SELF-INJURIOUS IDEATION 4 0.0010
158 DILATATION VENTRICULAR 2 0.0010
159 PRODUCT PACKAGING ISSUE 9 0.0009
160 SLEEP APNOEA SYNDROME 18 0.0009
161 PHARYNGITIS STREPTOCOCCAL 10 0.0009
162 BIPOLAR DISORDER 10 0.0009
163 CERVICAL DYSPLASIA 2 0.0009
164 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
165 VAGINAL DISCHARGE 9 0.0009
166 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
167 BLOOD LOSS ANAEMIA 2 0.0009
168 HAEMATOCRIT INCREASED 2 0.0009
169 BRAIN OPERATION 2 0.0009
170 MENOPAUSAL SYMPTOMS 2 0.0009
171 PULMONARY INFARCTION 2 0.0008
172 REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE 3 0.0008
173 APPENDICECTOMY 3 0.0008
174 MEDICATION RESIDUE PRESENT 4 0.0008
175 DEVICE PLACEMENT ISSUE 3 0.0008
176 LEARNING DISORDER 2 0.0008
177 MAJOR DEPRESSION 6 0.0008
178 UTERINE LEIOMYOMA 6 0.0008
179 HORMONE LEVEL ABNORMAL 4 0.0008
180 ALCOHOL USE 3 0.0008
181 INFREQUENT BOWEL MOVEMENTS 2 0.0008
182 INFUSION SITE SWELLING 5 0.0008
183 AUTOIMMUNE THYROIDITIS 3 0.0008
184 DERMATITIS CONTACT 9 0.0008
185 EXCORIATION 2 0.0008
186 APPENDICITIS PERFORATED 2 0.0008
187 THYROID MASS 3 0.0008
188 LACTOSE INTOLERANCE 2 0.0008
189 GENITAL HAEMORRHAGE 10 0.0008
190 OPTIC NEURITIS 7 0.0008
191 VENOUS THROMBOSIS 3 0.0008
192 POLYDIPSIA 3 0.0008
193 BREAST PAIN 8 0.0007
194 ALCOHOL ABUSE 2 0.0007
195 INTRACRANIAL ANEURYSM 3 0.0007
196 PRODUCT SUBSTITUTION ISSUE 43 0.0007
197 SKIN DISCOMFORT 2 0.0007
198 BLOOD SODIUM INCREASED 2 0.0007
199 SKIN WRINKLING 2 0.0007
200 CLUMSINESS 2 0.0007
201 SEASONAL ALLERGY 10 0.0007
202 OVARIAN CYST 7 0.0007
203 PULMONARY EMBOLISM 66 0.0007
204 PNEUMOTHORAX 11 0.0007
205 SKIN SWELLING 6 0.0007
206 STRABISMUS 2 0.0007
207 DECREASED INTEREST 4 0.0007
208 HEPATITIS FULMINANT 2 0.0007
209 LOSS OF EMPLOYMENT 2 0.0007
210 SELF INJURIOUS BEHAVIOUR 2 0.0007
211 INJECTION SITE PAPULE 3 0.0007
212 IRON DEFICIENCY ANAEMIA 6 0.0006
213 FOOD ALLERGY 5 0.0006
214 SCOLIOSIS 4 0.0006
215 EYELIDS PRURITUS 2 0.0006
216 AFFECTIVE DISORDER 5 0.0006
217 ABDOMINAL ADHESIONS 2 0.0006
218 IRIDOCYCLITIS 2 0.0006
219 ABDOMINAL PAIN LOWER 16 0.0006
220 PRE-ECLAMPSIA 3 0.0006
221 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
222 BLADDER PAIN 2 0.0006
223 BILE DUCT STONE 2 0.0006
224 IMPAIRED QUALITY OF LIFE 9 0.0006
225 PORTAL VEIN THROMBOSIS 2 0.0006
226 VITAMIN D DEFICIENCY 6 0.0006
227 HEPATIC NEOPLASM 2 0.0006
228 LYMPHOCYTE COUNT INCREASED 2 0.0006
229 HEPATOMEGALY 6 0.0006
230 BREAST ENLARGEMENT 2 0.0006
231 SOMNAMBULISM 4 0.0006
232 INFUSION SITE HAEMORRHAGE 2 0.0006
233 DERMATITIS ATOPIC 32 0.0006
234 LIGAMENT SPRAIN 6 0.0006
235 SUSPECTED COVID-19 2 0.0006
236 OTITIS MEDIA 2 0.0006
237 ABDOMINAL TENDERNESS 3 0.0006
238 APPETITE DISORDER 4 0.0006
239 ANXIETY DISORDER 2 0.0006
240 POST-TRAUMATIC STRESS DISORDER 4 0.0006
241 MOOD SWINGS 19 0.0006
242 VULVOVAGINAL PRURITUS 3 0.0006
243 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
244 DRUG EXPOSURE DURING PREGNANCY 20 0.0006
245 CHOLECYSTITIS 7 0.0006
246 LEFT VENTRICULAR FAILURE 2 0.0006
247 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
248 TONSILLITIS 3 0.0006
249 ACUTE RESPIRATORY FAILURE 11 0.0006
250 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
251 SERUM FERRITIN INCREASED 3 0.0006
252 INCONTINENCE 6 0.0006
253 MIGRAINE 54 0.0006
254 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
255 HEART DISEASE CONGENITAL 2 0.0006
256 MACULOPATHY 2 0.0006
257 FACIAL PAIN 5 0.0006
258 FOREIGN BODY IN REPRODUCTIVE TRACT 5 0.0006
259 POOR QUALITY SLEEP 12 0.0006
260 VISUAL FIELD DEFECT 4 0.0006
261 LUPUS-LIKE SYNDROME 5 0.0006
262 MONOCYTE COUNT INCREASED 2 0.0006
263 LIVER TRANSPLANT 2 0.0005
264 PANIC ATTACK 20 0.0005
265 CYSTIC FIBROSIS 3 0.0005
266 INTRACRANIAL PRESSURE INCREASED 3 0.0005
267 HYPERACUSIS 2 0.0005
268 IMPULSIVE BEHAVIOUR 2 0.0005
269 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
270 PAROSMIA 4 0.0005
271 INTENTIONAL DOSE OMISSION 15 0.0005
272 MUSCULOSKELETAL DISCOMFORT 9 0.0005
273 CONCUSSION 4 0.0005
274 APNOEA 4 0.0005
275 IMPAIRED GASTRIC EMPTYING 7 0.0005
276 MOOD ALTERED 14 0.0005
277 CERVIX CARCINOMA 2 0.0005
278 BRAIN FOG 8 0.0005
279 SKIN ODOUR ABNORMAL 2 0.0005
280 OESOPHAGEAL PAIN 2 0.0005
281 GASTROENTERITIS VIRAL 9 0.0005
282 HEPATITIS CHOLESTATIC 3 0.0005
283 ECZEMA 26 0.0005
284 NIGHT SWEATS 16 0.0005
285 ENURESIS 2 0.0005
286 FRUSTRATION TOLERANCE DECREASED 4 0.0005
287 CHROMATURIA 11 0.0005
288 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
289 INJURY 34 0.0005
290 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 2 0.0005
291 SUICIDAL IDEATION 44 0.0005
292 LIVE BIRTH 4 0.0005
293 SWELLING OF EYELID 3 0.0005
294 BLEPHAROSPASM 3 0.0005
295 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
296 PHOTOPSIA 3 0.0005
297 INFUSION SITE ERYTHEMA 4 0.0005
298 INCREASED APPETITE 9 0.0005
299 SCREAMING 3 0.0005
300 ENTERITIS 3 0.0005
301 PURULENT DISCHARGE 2 0.0005
302 MYDRIASIS 6 0.0005
303 GALACTORRHOEA 3 0.0005
304 TENSION HEADACHE 2 0.0005
305 HYPOAESTHESIA ORAL 7 0.0005
306 DEEP VEIN THROMBOSIS 30 0.0005
307 CHAPPED LIPS 2 0.0005
308 IMMOBILE 2 0.0005
309 URINE OUTPUT DECREASED 4 0.0005
310 DEPRESSION 104 0.0005
311 PRODUCT FORMULATION ISSUE 3 0.0005
312 SARS-COV-2 TEST POSITIVE 6 0.0005
313 LIGAMENT RUPTURE 2 0.0005
314 ABDOMINAL ABSCESS 2 0.0005
315 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
316 RHINITIS ALLERGIC 2 0.0004
317 MALNUTRITION 5 0.0004
318 WRONG PRODUCT ADMINISTERED 3 0.0004
319 PAPILLOEDEMA 2 0.0004
320 LIP DRY 4 0.0004
321 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
322 HAEMOGLOBIN INCREASED 2 0.0004
323 ISCHAEMIA 2 0.0004
324 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
325 MUSCLE TIGHTNESS 7 0.0004
326 AUTOIMMUNE HEPATITIS 3 0.0004
327 FORMICATION 3 0.0004
328 HUNGER 6 0.0004
329 EXTRASYSTOLES 3 0.0004
330 CAESAREAN SECTION 5 0.0004
331 BLOOD PROLACTIN INCREASED 2 0.0004
332 SKIN ABRASION 2 0.0004
333 SINUS TACHYCARDIA 6 0.0004
334 SPINAL DISORDER 4 0.0004
335 FUNGAL INFECTION 14 0.0004
336 ANHEDONIA 11 0.0004
337 CHOLESTASIS 8 0.0004
338 PANIC REACTION 3 0.0004
339 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
340 NOCTURIA 5 0.0004
341 INTENTIONAL UNDERDOSE 3 0.0004
342 SKIN FISSURES 8 0.0004
343 KIDNEY INFECTION 8 0.0004
344 INJECTION SITE URTICARIA 10 0.0004
345 BLINDNESS TRANSIENT 3 0.0004
346 HYPOPHOSPHATAEMIA 3 0.0004
347 EXPIRED DRUG ADMINISTERED 2 0.0004
348 PHARYNGITIS 5 0.0004
349 COMPLICATION OF DEVICE INSERTION 8 0.0004
350 PANCREATITIS ACUTE 9 0.0004
351 PREGNANCY 8 0.0004
352 ABORTION SPONTANEOUS 16 0.0004
353 PROCEDURAL PAIN 11 0.0004
354 CHOLELITHIASIS 13 0.0004
355 ACNE 30 0.0004
356 DRUG TOLERANCE 2 0.0004
357 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
358 INITIAL INSOMNIA 4 0.0004
359 INJECTION SITE WARMTH 8 0.0004
360 CEREBRAL ISCHAEMIA 2 0.0004
361 MUSCULOSKELETAL CHEST PAIN 6 0.0004
362 ANKLE FRACTURE 6 0.0004
363 CONGENITAL ANOMALY 3 0.0004
364 ANXIETY 109 0.0004
365 FOOD CRAVING 2 0.0004
366 ANKYLOSING SPONDYLITIS 5 0.0004
367 JOINT DISLOCATION 4 0.0004
368 DEPRESSED MOOD 20 0.0004
369 RESPIRATORY TRACT CONGESTION 6 0.0004
370 ANORECTAL DISCOMFORT 2 0.0004
371 NECK PAIN 21 0.0004
372 HAIR TEXTURE ABNORMAL 5 0.0004
373 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
374 FOOD POISONING 2 0.0004
375 SENSORY LOSS 3 0.0004
376 PHOTOPHOBIA 7 0.0004
377 BRUXISM 2 0.0004
378 SINUSITIS 38 0.0004
379 BEHAVIOUR DISORDER 2 0.0004
380 NORMAL NEWBORN 2 0.0004
381 PRODUCT DISPENSING ERROR 8 0.0004
382 OESOPHAGITIS 4 0.0004
383 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
384 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
385 HYPERAESTHESIA 3 0.0004
386 ESCHERICHIA INFECTION 3 0.0004
387 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
388 HAIR DISORDER 3 0.0004
389 NERVE INJURY 4 0.0004
390 STREPTOCOCCAL INFECTION 2 0.0004
391 INJECTION SITE PRURITUS 24 0.0004
392 CRYING 13 0.0004
393 DISEASE RECURRENCE 17 0.0004
394 EMOTIONAL DISORDER 11 0.0004
395 SKIN REACTION 5 0.0004
396 GRANULOCYTOPENIA 2 0.0004
397 CHOLECYSTECTOMY 4 0.0003
398 NEUROLOGICAL SYMPTOM 2 0.0003
399 TINNITUS 16 0.0003
400 PSYCHOLOGICAL TRAUMA 3 0.0003
401 HYSTERECTOMY 3 0.0003
402 HYPOKINESIA 5 0.0003
403 DISCOMFORT 21 0.0003
404 DRY EYE 17 0.0003
405 ENERGY INCREASED 2 0.0003
406 EXPOSURE DURING PREGNANCY 21 0.0003
407 BLOOD IRON DECREASED 4 0.0003
408 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
409 ACCIDENT 4 0.0003
410 OROPHARYNGEAL DISCOMFORT 3 0.0003
411 COMPLICATION OF DEVICE REMOVAL 6 0.0003
412 WEIGHT INCREASED 74 0.0003
413 SEIZURE 38 0.0003
414 DRUG DISPENSING ERROR 5 0.0003
415 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
416 MENISCUS INJURY 2 0.0003
417 NERVE COMPRESSION 3 0.0003
418 PIGMENTATION DISORDER 2 0.0003
419 PRURITUS GENERALISED 7 0.0003
420 CHOLANGITIS 2 0.0003
421 CHEST DISCOMFORT 33 0.0003
422 INJECTION SITE REACTION 22 0.0003
423 IRRITABILITY 19 0.0003
424 ABDOMINAL PAIN UPPER 65 0.0003
425 EYE INFLAMMATION 3 0.0003
426 FOREIGN BODY SENSATION IN EYES 2 0.0003
427 ABSCESS 5 0.0003
428 LYMPHADENOPATHY 11 0.0003
429 MUSCLE SPASMS 57 0.0003
430 ATELECTASIS 3 0.0003
431 INFUSION SITE PAIN 4 0.0003
432 SYNCOPE 31 0.0003
433 HYPERPROLACTINAEMIA 2 0.0003
434 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
435 HEPATITIS ACUTE 2 0.0003
436 RESPIRATORY TRACT INFECTION 8 0.0003
437 PRODUCT DOSE OMISSION 20 0.0003
438 NASAL CONGESTION 18 0.0003
439 NAUSEA 242 0.0003
440 BEDRIDDEN 4 0.0003
441 GASTRITIS 8 0.0003
442 TOOTH INFECTION 4 0.0003
443 C-REACTIVE PROTEIN INCREASED 11 0.0003
444 BLADDER DISORDER 3 0.0003
445 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
446 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
447 EAR INFECTION 8 0.0003
448 MENINGITIS 2 0.0003
449 BLOOD POTASSIUM DECREASED 9 0.0003
450 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
451 QUALITY OF LIFE DECREASED 4 0.0003
452 SLEEP DISORDER 21 0.0003
453 ABDOMINAL DISTENSION 31 0.0003
454 UVEITIS 4 0.0003
455 SUBARACHNOID HAEMORRHAGE 3 0.0003
456 MOTOR DYSFUNCTION 3 0.0003
457 PALLOR 8 0.0003
458 EYE MOVEMENT DISORDER 2 0.0003
459 ASTHMA 33 0.0003
460 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
461 UNEVALUABLE EVENT 22 0.0003
462 TEMPERATURE INTOLERANCE 3 0.0003
463 LYMPHOEDEMA 2 0.0003
464 VENTRICULAR EXTRASYSTOLES 3 0.0003
465 PRESYNCOPE 7 0.0003
466 TENDERNESS 3 0.0003
467 ORAL DISCOMFORT 4 0.0003
468 HEADACHE 180 0.0003
469 APHONIA 4 0.0003
470 DERMATITIS 6 0.0003
471 HEAD DISCOMFORT 5 0.0003
472 PAIN IN JAW 8 0.0003
473 INJECTION SITE ERYTHEMA 35 0.0003
474 RETCHING 6 0.0003
475 IMPAIRED WORK ABILITY 6 0.0003
476 THIRST 5 0.0003
477 IRRITABLE BOWEL SYNDROME 6 0.0003
478 BACK PAIN 65 0.0003
479 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
480 ANOSMIA 4 0.0003
481 PULMONARY THROMBOSIS 3 0.0003
482 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
483 URTICARIA 46 0.0003
484 SURGERY 16 0.0003
485 GASTROINTESTINAL PAIN 3 0.0003
486 INJECTION SITE NODULE 3 0.0003
487 UNRESPONSIVE TO STIMULI 7 0.0003
488 PSYCHIATRIC SYMPTOM 2 0.0003
489 CONTUSION 26 0.0003
490 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
491 CONJUNCTIVITIS 5 0.0003
492 FEELING DRUNK 2 0.0003
493 HEPATIC STEATOSIS 5 0.0003
494 MIDDLE INSOMNIA 5 0.0003
495 HAEMORRHAGE INTRACRANIAL 4 0.0003
496 OCULAR DISCOMFORT 3 0.0003
497 SWELLING 25 0.0003
498 STATUS EPILEPTICUS 3 0.0003
499 TENDON PAIN 2 0.0003
500 VOMITING 124 0.0003
501 BLOOD URINE PRESENT 5 0.0003
502 INJECTION SITE BRUISING 21 0.0003
503 MICTURITION URGENCY 3 0.0003
504 VERTIGO 16 0.0003
505 FEELING JITTERY 5 0.0003
506 DRY SKIN 35 0.0003
507 MYOCARDITIS 3 0.0003
508 BOWEL MOVEMENT IRREGULARITY 2 0.0003
509 THROMBOSIS 21 0.0003
510 LIPASE INCREASED 2 0.0003
511 FEELING HOT 16 0.0003
512 INJECTION SITE RASH 8 0.0003
513 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
514 MUSCLE TWITCHING 6 0.0003
515 OROPHARYNGEAL PAIN 24 0.0003
516 ELECTROLYTE IMBALANCE 3 0.0003
517 APHTHOUS ULCER 2 0.0003
518 EAR PAIN 5 0.0003
519 HAEMORRHOIDS 5 0.0003
520 HYPERHIDROSIS 33 0.0003
521 MENINGIOMA 4 0.0003
522 ORAL HERPES 5 0.0003
523 HAEMORRHAGIC STROKE 2 0.0003
524 FLUSHING 26 0.0003
525 MULTIPLE ALLERGIES 2 0.0003
526 DRUG-INDUCED LIVER INJURY 8 0.0003
527 THERAPY CESSATION 13 0.0003
528 DEVICE DISLOCATION 11 0.0003
529 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
530 FURUNCLE 2 0.0003
531 NASAL DISCOMFORT 2 0.0003
532 INFLAMMATION 13 0.0003
533 BLOOD PRESSURE ABNORMAL 5 0.0003
534 PREMATURE DELIVERY 4 0.0003
535 MUSCLE RIGIDITY 3 0.0003
536 COVID-19 44 0.0003
537 FEELING ABNORMAL 60 0.0003
538 ALOPECIA 49 0.0002
539 MOVEMENT DISORDER 8 0.0002
540 SOMNOLENCE 50 0.0002
541 RHINITIS 2 0.0002
542 DRUG DOSE OMISSION 41 0.0002
543 HYPERSENSITIVITY 46 0.0002
544 MYASTHENIA GRAVIS 2 0.0002
545 PALPITATIONS 29 0.0002
546 HYPOAESTHESIA 37 0.0002
547 MUSCLE DISORDER 2 0.0002
548 FIBROMYALGIA 6 0.0002
549 NEURALGIA 6 0.0002
550 PSORIATIC ARTHROPATHY 10 0.0002
551 COLITIS ULCERATIVE 11 0.0002
552 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
553 RESPIRATORY DEPRESSION 3 0.0002
554 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
555 IMPAIRED HEALING 8 0.0002
556 INFLUENZA LIKE ILLNESS 20 0.0002
557 PHOTOSENSITIVITY REACTION 4 0.0002
558 LOSS OF CONSCIOUSNESS 31 0.0002
559 PARAESTHESIA 38 0.0002
560 DISTURBANCE IN ATTENTION 13 0.0002
561 VIRAL INFECTION 8 0.0002
562 ATRIAL SEPTAL DEFECT 2 0.0002
563 ANGER 8 0.0002
564 FLUID RETENTION 12 0.0002
565 INJECTION SITE SWELLING 18 0.0002
566 HEPATITIS 6 0.0002
567 SCAR 4 0.0002
568 NASOPHARYNGITIS 43 0.0002
569 VISION BLURRED 32 0.0002
570 INSOMNIA 62 0.0002
571 LACRIMATION INCREASED 7 0.0002
572 DIPLOPIA 6 0.0002
573 THERAPEUTIC RESPONSE DECREASED 14 0.0002
574 EYE PAIN 13 0.0002
575 PSORIASIS 30 0.0002
576 BRONCHITIS 17 0.0002
577 MUSCULAR WEAKNESS 26 0.0002
578 JOINT STIFFNESS 6 0.0002
579 ABDOMINAL PAIN 53 0.0002
580 SPINAL OSTEOARTHRITIS 2 0.0002
581 IMMUNOSUPPRESSION 2 0.0002
582 LUNG INFILTRATION 2 0.0002
583 INFUSION RELATED REACTION 15 0.0002
584 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
585 RESPIRATORY RATE INCREASED 2 0.0002
586 GALLBLADDER DISORDER 4 0.0002
587 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
588 FATIGUE 174 0.0002
589 PREGNANCY WITH CONTRACEPTIVE DEVICE 2 0.0002
590 EMOTIONAL DISTRESS 27 0.0002
591 ANAL INCONTINENCE 2 0.0002
592 BLOOD BILIRUBIN INCREASED 6 0.0002
593 HEART RATE INCREASED 22 0.0002
594 PRODUCT TASTE ABNORMAL 3 0.0002
595 TOOTHACHE 4 0.0002
596 CONDITION AGGRAVATED 67 0.0002
597 CYSTITIS 7 0.0002
598 HIDRADENITIS 2 0.0002
599 INCREASED TENDENCY TO BRUISE 2 0.0002
600 DIZZINESS 108 0.0002
601 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
602 PRODUCT DISTRIBUTION ISSUE 2 0.0002
603 PERSONALITY CHANGE 2 0.0002
604 INFLUENZA 24 0.0002
605 ROAD TRAFFIC ACCIDENT 9 0.0002
606 EYE SWELLING 8 0.0002
607 SWELLING FACE 14 0.0002
608 MASS 3 0.0002
609 PRODUCT DOSE OMISSION ISSUE 63 0.0002
610 DIARRHOEA HAEMORRHAGIC 2 0.0002
611 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
612 EYE DISORDER 7 0.0002
613 INJECTION SITE HAEMORRHAGE 17 0.0002
614 HOT FLUSH 16 0.0002
615 STAPHYLOCOCCAL INFECTION 7 0.0002
616 BLOOD SODIUM DECREASED 4 0.0002
617 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
618 SUBDURAL HAEMATOMA 3 0.0002
619 HYPERSOMNIA 6 0.0002
620 EYE PRURITUS 7 0.0002
621 BLOOD PRESSURE FLUCTUATION 5 0.0002
622 PARAESTHESIA ORAL 3 0.0002
623 AFFECT LABILITY 2 0.0002
624 MENTAL DISORDER 9 0.0002
625 LOCALISED INFECTION 5 0.0002
626 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
627 APATHY 3 0.0002
628 CHEST PAIN 38 0.0002
629 INFLAMMATORY BOWEL DISEASE 2 0.0002
630 WEIGHT DECREASED 57 0.0002
631 RASH 89 0.0002
632 KNEE OPERATION 2 0.0002
633 PSYCHOTIC DISORDER 6 0.0002
634 TACHYCARDIA 18 0.0002
635 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
636 HAEMATOCRIT DECREASED 4 0.0002
637 IMMUNODEFICIENCY 3 0.0002
638 THROAT IRRITATION 9 0.0002
639 HYPOTONIA 2 0.0002
640 BURNING SENSATION 14 0.0002
641 BRAIN INJURY 2 0.0002
642 PREMATURE BABY 6 0.0002
643 ANAPHYLACTIC REACTION 11 0.0002
644 INTENTIONAL SELF-INJURY 4 0.0002
645 ECONOMIC PROBLEM 3 0.0002
646 PRODUCT ADMINISTRATION ERROR 4 0.0002
647 DEVICE BREAKAGE 8 0.0002
648 EYELID PTOSIS 2 0.0002
649 INSURANCE ISSUE 3 0.0002
650 SLUGGISHNESS 2 0.0002
651 THERAPY INTERRUPTED 14 0.0002
652 EUPHORIC MOOD 2 0.0002
653 EAR DISCOMFORT 2 0.0002
654 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
655 ANAPHYLACTIC SHOCK 5 0.0002
656 DELUSION 3 0.0002
657 RASH GENERALISED 5 0.0002
658 TREMOR 32 0.0002
659 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
660 PULMONARY HYPERTENSION 4 0.0002
661 POLLAKIURIA 8 0.0002
662 MUSCULOSKELETAL PAIN 10 0.0002
663 CYANOSIS 3 0.0002
664 FOLLICULITIS 2 0.0002
665 DYSURIA 7 0.0002
666 SKIN EXFOLIATION 16 0.0002
667 SCRATCH 2 0.0002
668 ADVERSE DRUG REACTION 17 0.0002
669 PAIN 116 0.0002
670 HALLUCINATION, AUDITORY 3 0.0002
671 OBESITY 3 0.0002
672 RASH ERYTHEMATOUS 9 0.0002
673 HYPOTHYROIDISM 6 0.0002
674 SENSORY DISTURBANCE 3 0.0002
675 FEAR 5 0.0002
676 PAIN OF SKIN 5 0.0002
677 FREQUENT BOWEL MOVEMENTS 5 0.0002
678 DEVICE EXPULSION 12 0.0002
679 THROAT TIGHTNESS 5 0.0002
680 PRURITUS 71 0.0002
681 RASH PRURITIC 10 0.0002
682 PRODUCT QUALITY ISSUE 25 0.0002
683 BACK INJURY 2 0.0002
684 PRODUCT PRESCRIBING ISSUE 4 0.0002
685 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
686 SUICIDE ATTEMPT 11 0.0002
687 DENTAL CARIES 2 0.0002
688 PLEURAL EFFUSION 11 0.0002
689 LIP SWELLING 6 0.0002
690 URINARY RETENTION 6 0.0002
691 RASH PAPULAR 4 0.0002
692 SNEEZING 4 0.0002
693 BLOOD CALCIUM DECREASED 2 0.0002
694 VISUAL IMPAIRMENT 22 0.0002
695 EYE INFECTION 2 0.0002
696 REBOUND EFFECT 2 0.0002
697 DISORIENTATION 7 0.0002
698 PRODUCT AVAILABILITY ISSUE 4 0.0002
699 SCAB 2 0.0002
700 CONVULSION 10 0.0002
701 PARANOIA 3 0.0002
702 EYE IRRITATION 10 0.0002
703 MULTI-ORGAN FAILURE 3 0.0002
704 MALAISE 76 0.0002
705 EXTRA DOSE ADMINISTERED 7 0.0002
706 INJECTION SITE PAIN 53 0.0002
707 DRY MOUTH 14 0.0002
708 POST PROCEDURAL HAEMORRHAGE 2 0.0002
709 INTENTIONAL PRODUCT MISUSE 15 0.0002
710 URINARY TRACT INFECTION 29 0.0002
711 ACUTE MYOCARDIAL INFARCTION 5 0.0002
712 ARTHRALGIA 70 0.0002
713 DECREASED APPETITE 39 0.0002
714 COUGH 47 0.0002
715 GASTROINTESTINAL DISORDER 15 0.0002
716 HYPERLIPIDAEMIA 2 0.0002
717 ABDOMINAL DISCOMFORT 28 0.0002
718 WITHDRAWAL SYNDROME 7 0.0002
719 APHASIA 5 0.0002
720 RESTLESS LEGS SYNDROME 3 0.0002
721 DEHYDRATION 22 0.0002
722 TREATMENT NONCOMPLIANCE 9 0.0002
723 DIARRHOEA 106 0.0002
724 NO THERAPEUTIC RESPONSE 2 0.0002
725 DRUG INTERACTION 26 0.0002
726 AGITATION 12 0.0002
727 DRUG ADMINISTRATION ERROR 5 0.0002
728 DYSPEPSIA 16 0.0002
729 INJECTION SITE MASS 6 0.0002
730 DYSGEUSIA 12 0.0002
731 CYST 2 0.0002
732 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
733 HAIR COLOUR CHANGES 2 0.0002
734 BLISTER 9 0.0002
735 PRODUCT STORAGE ERROR 14 0.0002
736 SECRETION DISCHARGE 2 0.0002
737 DERMATITIS ALLERGIC 2 0.0002
738 PYREXIA 55 0.0002
739 BRAIN OEDEMA 2 0.0002
740 HEAD INJURY 5 0.0002
741 LIVER DISORDER 7 0.0002
742 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
743 POST PROCEDURAL COMPLICATION 3 0.0002
744 DRUG PRESCRIBING ERROR 3 0.0002
745 HYPERTENSION 33 0.0002
746 ANOREXIA 2 0.0002
747 RHINORRHOEA 10 0.0002
748 INJECTION SITE INDURATION 2 0.0002
749 PLATELET COUNT INCREASED 2 0.0002
750 NERVOUSNESS 8 0.0002
751 HAEMORRHAGE 16 0.0002
752 DEAFNESS 4 0.0002
753 SKIN DISCOLOURATION 7 0.0002
754 DISABILITY 3 0.0002
755 VISUAL ACUITY REDUCED 5 0.0002
756 BLOOD CHOLESTEROL INCREASED 7 0.0002
757 PAIN IN EXTREMITY 44 0.0001
758 MALIGNANT MELANOMA 2 0.0001
759 JOINT RANGE OF MOTION DECREASED 2 0.0001
760 JOINT SWELLING 18 0.0001
761 PRODUCT PHYSICAL ISSUE 3 0.0001
762 TYPE 2 DIABETES MELLITUS 5 0.0001
763 DRUG EFFECT DECREASED 8 0.0001
764 OCULAR HYPERAEMIA 7 0.0001
765 BLINDNESS 6 0.0001
766 DRUG TOXICITY 2 0.0001
767 DYSPNOEA 83 0.0001
768 MULTIPLE SCLEROSIS 7 0.0001
769 OSTEOPOROSIS 6 0.0001
770 CORONARY ARTERY OCCLUSION 2 0.0001
771 GASTRIC DISORDER 5 0.0001
772 MEMORY IMPAIRMENT 20 0.0001
773 PERITONITIS 3 0.0001
774 NIGHTMARE 5 0.0001
775 MENTAL STATUS CHANGES 4 0.0001
776 FEELING COLD 4 0.0001
777 PRODUCT USE ISSUE 27 0.0001
778 NO ADVERSE EVENT 26 0.0001
779 INTENTIONAL DRUG MISUSE 3 0.0001
780 CARPAL TUNNEL SYNDROME 2 0.0001
781 MOUTH ULCERATION 3 0.0001
782 HALLUCINATION, VISUAL 3 0.0001
783 ERYTHEMA 29 0.0001
784 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
785 BRONCHOSPASM 2 0.0001
786 RED BLOOD CELL COUNT DECREASED 4 0.0001
787 AGGRESSION 7 0.0001
788 CARDIOGENIC SHOCK 2 0.0001
789 LETHARGY 8 0.0001
790 BALANCE DISORDER 12 0.0001
791 AMNESIA 9 0.0001
792 HYPERTHYROIDISM 2 0.0001
793 BLOOD PRESSURE INCREASED 21 0.0001
794 MUSCULOSKELETAL STIFFNESS 12 0.0001
795 RESTLESSNESS 5 0.0001
796 LABORATORY TEST ABNORMAL 4 0.0001
797 MYALGIA 23 0.0001
798 STEVENS-JOHNSON SYNDROME 3 0.0001
799 TRANSAMINASES INCREASED 3 0.0001
800 TOOTH DISORDER 3 0.0001
801 HEPATOTOXICITY 3 0.0001
802 GLOSSODYNIA 3 0.0001
803 DEVICE ISSUE 12 0.0001
804 HEART RATE IRREGULAR 3 0.0001
805 RHEUMATOID ARTHRITIS 15 0.0001
806 HEPATIC ENZYME INCREASED 9 0.0001
807 INCORRECT DOSE ADMINISTERED 30 0.0001
808 EPILEPSY 4 0.0001
809 PHARYNGEAL OEDEMA 2 0.0001
810 PERIPHERAL SWELLING 20 0.0001
811 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
812 EJECTION FRACTION DECREASED 2 0.0001
813 CONSTIPATION 28 0.0001
814 NERVOUS SYSTEM DISORDER 4 0.0001
815 CHILLS 15 0.0001
816 ARTHRITIS 10 0.0001
817 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
818 ABNORMAL BEHAVIOUR 5 0.0001
819 ILLNESS 13 0.0001
820 SKIN BURNING SENSATION 9 0.0001
821 BLOOD GLUCOSE DECREASED 6 0.0001
822 INFECTION 18 0.0001
823 MANIA 2 0.0001
824 DRUG INEFFECTIVE 160 0.0001
825 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
826 BLOOD PRESSURE DECREASED 8 0.0001
827 AGEUSIA 3 0.0001
828 GAIT DISTURBANCE 23 0.0001
829 COAGULOPATHY 2 0.0001
830 SKIN DISORDER 4 0.0001
831 CELLULITIS 6 0.0001
832 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
833 CANDIDA INFECTION 2 0.0001
834 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
835 HEMIPARESIS 2 0.0001
836 OSTEOARTHRITIS 5 0.0001
837 HYPOPHAGIA 3 0.0001
838 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
839 DYSPHAGIA 11 0.0001
840 NEUROPATHY PERIPHERAL 11 0.0001
841 OEDEMA PERIPHERAL 14 0.0001
842 ORTHOSTATIC HYPOTENSION 2 0.0001
843 MUCOSAL INFLAMMATION 3 0.0001
844 DEVICE USE ISSUE 2 0.0001
845 SYRINGE ISSUE 2 0.0001
846 HEART RATE DECREASED 4 0.0001
847 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 23 0.0001
848 COLD SWEAT 2 0.0001
849 ANGIOEDEMA 5 0.0001
850 CEREBROVASCULAR ACCIDENT 19 0.0001
851 ISCHAEMIC STROKE 2 0.0001
852 OFF LABEL USE 98 0.0001
853 PULMONARY OEDEMA 5 0.0001
854 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
855 JAUNDICE 3 0.0001
856 OEDEMA 6 0.0001
857 OSTEOMYELITIS 2 0.0001
858 LIMB INJURY 3 0.0001
859 UNDERDOSE 8 0.0001
860 SKIN LESION 3 0.0001
861 SKIN IRRITATION 5 0.0001
862 ABNORMAL DREAMS 3 0.0001
863 ARTHROPATHY 6 0.0001
864 WOUND 3 0.0001
865 BACTERIAL INFECTION 2 0.0001
866 DYSARTHRIA 4 0.0001
867 HALLUCINATION 8 0.0001
868 INTESTINAL OBSTRUCTION 4 0.0001
869 FLATULENCE 6 0.0001
870 GASTRIC ULCER 2 0.0001
871 PROTEINURIA 2 0.0001
872 CONFUSIONAL STATE 17 0.0001
873 PRODUCTIVE COUGH 5 0.0001
874 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
875 GLAUCOMA 2 0.0001
876 ASTHENIA 39 0.0001
877 HERNIA 2 0.0001
878 PRESCRIBED OVERDOSE 2 0.0001
879 DYSTONIA 2 0.0001
880 DYSSTASIA 3 0.0001
881 DRUG WITHDRAWAL SYNDROME 9 0.0001
882 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
883 URINARY INCONTINENCE 3 0.0001
884 PRESCRIBED UNDERDOSE 2 0.0001
885 SPINAL FRACTURE 2 0.0001
886 HEPATIC FAILURE 3 0.0001
887 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
888 FEEDING DISORDER 2 0.0001
889 TASTE DISORDER 2 0.0001
890 DYSKINESIA 4 0.0001
891 BODY TEMPERATURE INCREASED 2 0.0001
892 ADVERSE EVENT 9 0.0001
893 PRODUCT PREPARATION ERROR 2 0.0001
894 RIB FRACTURE 2 0.0001
895 LIMB DISCOMFORT 3 0.0001
896 SPEECH DISORDER 5 0.0001
897 PANCREATITIS 5 0.0001
898 EATING DISORDER 2 0.0001
899 JOINT INJURY 2 0.0001
900 EPISTAXIS 7 0.0001
901 DRUG INTOLERANCE 9 0.0001
902 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
903 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
904 RASH MACULO-PAPULAR 2 0.0001
905 ORAL PAIN 2 0.0001
906 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
907 HAEMOGLOBIN DECREASED 9 0.0001
908 RASH MACULAR 3 0.0001
909 COGNITIVE DISORDER 4 0.0001
910 HYPOXIA 3 0.0001
911 HYPOTENSION 17 0.0001
912 ARRHYTHMIA 4 0.0001
913 WHEEZING 5 0.0001
914 FALL 28 0.0001
915 PRODUCT PRESCRIBING ERROR 2 0.0001
916 ANAEMIA 16 0.0001
917 MOBILITY DECREASED 6 0.0001
918 DRUG EFFECT INCOMPLETE 3 0.0001
919 MENTAL IMPAIRMENT 2 0.0001
920 CEREBRAL INFARCTION 2 0.0001
921 PNEUMONIA 26 0.0001
922 PNEUMONIA ASPIRATION 2 0.0001
923 COLITIS 3 0.0001
924 HAEMATOMA 2 0.0001
925 EXPOSURE VIA SKIN CONTACT 2 0.0001
926 DEVICE MALFUNCTION 5 0.0001
927 RENAL FAILURE ACUTE 3 0.0001
928 RECTAL HAEMORRHAGE 3 0.0001
929 HYPOACUSIS 3 0.0001
930 DYSPHONIA 4 0.0001
931 BONE PAIN 4 0.0001
932 ASCITES 2 0.0001
933 RESPIRATORY DISORDER 2 0.0001
934 STOMATITIS 4 0.0001
935 HYPOKALAEMIA 3 0.0001
936 RENAL DISORDER 3 0.0001
937 SEPSIS 7 0.0001
938 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
939 INTENTIONAL OVERDOSE 4 0.0001
940 INTERSTITIAL LUNG DISEASE 3 0.0001
941 DEVICE DIFFICULT TO USE 4 0.0001
942 TREATMENT FAILURE 5 0.0001
943 EXPIRED PRODUCT ADMINISTERED 2 0.0001
944 HAEMATURIA 2 0.0001
945 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
946 DEVICE USE ERROR 2 0.0001
947 BRADYCARDIA 3 0.0001
948 PLATELET COUNT DECREASED 6 0.0001
949 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
950 RESPIRATORY FAILURE 4 0.0001
951 ACCIDENTAL OVERDOSE 2 0.0001
952 THROMBOCYTOPENIA 6 0.0001
953 BREAST CANCER 5 0.0001
954 HEPATIC FUNCTION ABNORMAL 2 0.0001
955 OXYGEN SATURATION DECREASED 3 0.0001
956 DYSPNOEA EXERTIONAL 2 0.0001
957 BLOOD GLUCOSE INCREASED 10 0.0001
958 DIABETES MELLITUS 4 0.0001
959 HERPES ZOSTER 3 0.0001
960 CARDIAC ARREST 4 0.0000
961 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
962 CARDIO-RESPIRATORY ARREST 2 0.0000
963 DEVICE LEAKAGE 2 0.0000
964 FEBRILE NEUTROPENIA 3 0.0000
965 NEOPLASM MALIGNANT 3 0.0000
966 NEPHROLITHIASIS 2 0.0000
967 DISEASE PROGRESSION 5 0.0000
968 COMA 2 0.0000
969 HYPOGLYCAEMIA 2 0.0000
970 LUNG DISORDER 2 0.0000
971 MYOCARDIAL INFARCTION 7 0.0000
972 LEUKOPENIA 2 0.0000
973 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
974 HAEMATOCHEZIA 2 0.0000
975 MEDICATION ERROR 2 0.0000
976 ILL-DEFINED DISORDER 2 0.0000
977 HOSPITALISATION 5 0.0000
978 CARDIAC DISORDER 3 0.0000
979 DRUG DEPENDENCE 5 0.0000
980 RENAL FAILURE 4 0.0000
981 TOXICITY TO VARIOUS AGENTS 5 0.0000
982 NEUTROPENIA 4 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
984 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
985 CHRONIC KIDNEY DISEASE 2 0.0000
986 CARDIAC FAILURE 2 0.0000
987 COMPLETED SUICIDE 2 0.0000
988 RENAL IMPAIRMENT 2 0.0000
989 OVERDOSE 5 0.0000
990 ATRIAL FIBRILLATION 2 0.0000
991 ACUTE KIDNEY INJURY 3 0.0000
992 DEATH 9 0.0000